Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells

Chinese Medical Journal

Volumn 121, Issue 5, 2008, Pages 463-468

  Shen, Shao Hua ^a   Gu, Long Jun ^a   Liu, Pei Qing ^b   Ye, Xin ^c   Chang, Wei Shan ^d   Li, Ben Shang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c Taian Central Hospital   (China)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Adriamycin; Leukemia; Multidrug resistance; Proteomics

Indexed keywords

CRK LIKE PROTEIN; DOXORUBICIN; SMALL INTERFERING RNA; STATHMIN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STMN1 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; GEL ELECTROPHORESIS; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LENTIVIRINAE; LEUKEMIA CELL; MASS SPECTROMETRY; MULTIDRUG RESISTANCE; PROTEIN EXPRESSION; PROTEOMICS; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; AMINO ACID SEQUENCE; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MOLECULAR GENETICS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; HUMANS; K562 CELLS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEOMICS; STATHMIN;

EID: 42449114446     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200803010-00019     Document Type: Article

References (27)

1. Suarez L, Vidriales MB, Moreno MJ, Lopez A, Garcia-Larana J, Perez-Lopez C, et al. Diffetence in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells. Haematologica 2005; 90: 54-59.
2. Riordan JR, Ling V. Genetic and biochemical characterization of multidrug resistance. Pharmacol Ther 1985; 28; 51-75.
3. Luqmani YA. Mechanisms of drug resistance in cancer chemotherapy. Med Princ Pract 2005; 14: 35-48.
4. Spiegl-Kreinecker S, Buchroithnier J, Elbling L, Steiner E, Wurm G, Bodenteich A, et al. Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein I in human brain tumor cells and astrocytes. J Neurooncol 2002; 57: 27-36.
5. Marian T, Szabo G, Goda K, Nagy H, Szincsak N, Juhasz I, et al In vivo and in vitro multitracer analysis of P-gylycoprotein expression-related multidrug resistance. Eur J Nucl Med Mol Imaging 2003; 30: 1147-1154.
6. Su Y, Lee SH, Sinko PJ. Inhibition of efflux transporter ABCG2/BCRP does not restore mitoxantrone sensitivity in irinotecan-selected human leukemia CPT-K5 cells: evidence for multifactorial multidrug resistance. Eur J Pharm Sci 2006; 29:102-110.
7. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250: 4O07-4021.
8. Gorg A, Postel W, Gunther S. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1988; 9: 531-646.
9. Dongre AR, Eng JK, Yates JR 3rd. Emerging tandem-mass-spectrometry techniques for the rapid identification of proteins. Trends Biotechnol 1997; 15: 418-425.
10. Gygi SP, Han DK, Gingras AC, Sonenberg N, Aebersold R. Protein analysis by mass spectrometry and sequence database searching: tools for cancer research in the post-genomic era. Electrophoresis 1999; 20: 310-319.
11. Rout MP, Aitchison JD, Suprapto A, Hjertaas K, Zhao Y, Chait BT. The yeast nuclear pore complex: composition, architecture, and transport mechanism. J Cell Biol 2000; 148: 635-651.
12. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000; 21: 1037-1053.
13. Unlu M, Morgan ME, Minden JS. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997; 18: 2071-2077.
14. Gharbi S, Gaffney P, Yang A, Zvolebil MJ, Cramer R, Waterfield MD, et al. Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics 2002; 1: 91-98.
15. Schiffer CA, Hehlmann R, Larson R. Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL (1). Leukemia 2003; 17: 691-699.
16. Shen SH, Ye X, Chen LJ, Yang HY, Liu AH, Yang XY. Study on Lung resistance protein, PgP a4d bcl-2 gene protein expressing in multidrug resistance cell strain of K562. J Taishan Med College (Chin) 2000; 21: 204-206.
17. Meliksetian MB, Berezkina EV, Pavlenko MA, Grinchuk TM. Mechanism of drug resistance of two cell lines of human chronic promyelocytic leukemia K562, resistant to DNA topoisomerase II inhibitors adriamycin and etoposide. Tsitologiia 1999; 41: 615-621.
18. Wong TW, Yu HY, Kong SK, Fung KP, Kwok TT. The decrease of mitochondrial NADH dehydrogenease and drug induced apoptosis in doxorubicin resistant A431 cells. Life Sci 2000; 67: 1111-1118.
19. Verrills NM, Liem NL, Liaw TY, Hood BD, Lock RB, Kavallaris M. Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia an in vivo study. Proteomics 2006; 6: 1681-1694.
20. Song JH, Choi CH, Yeom HJ, Hwang SY, Kim TS. Monitoring the gene expression profiles of doxorubicin-resistant acute mylocytic leukemia cells by DNA microarray analysis. Life Sci 2006; 79: 10-202.
21. Ou K, Kesuma D, Ganesan K, Yu K, Soon SY, Lee SY, et al. Quantititive profiling of drug-associated proteomic alterations by combined 2-nitrobenzenesulfenyl chloride (NBS) isotope labeling and 2DE/MS identification. J Proteome Res 2006; 5: 2144-2206.
22. Uemura N, Salgia R, Li JL, Pisick JE, Sattler M, Griffin JD. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins. Leukemia 1997; 11: 376-385.
23. Felschow DM, McVeigh ML, Hoehn GT, Civin CI, Fackler MJ. The adapter protein CRKL associates with CD34. Blood 2001; 97: 3768-3775.
24. Wei HL, Wu YJ, Jing T, Bai DC, Ma LF. Sensitization and apoptosis augmentation of K562/ADM cells by anti-multidrug resistance gene peptide nucleic acid and antisense oligodeoxyribonucleotide. Acta Pharmacol Sin 2003; 24: 805-811.
25. Dassow H, Lassner D, Remke H, Preiss R. Modulation of multidrug resistance in human leakemia cells with mdr1-targeted antisense oligonucleotides using variable treatment schedules. Int J Clin Pharmacol Ther 2000; 38: 209-216.
26. Matsumoto Y, Miyake K, Kunishio K, Tamiya T, Seigo N. Reduction of expression of the multidrug resistance protein (MRP) 1 in glioma cells by antisense phosphorothioate oligonucleotides. J Med Invest 2004; 51: 194-201.
27. Anderson RD, Haskell R, Xia H, Roessler BJ, Davidson BL. A simple method for the rapid generation of recombinant adenovirus vectors. Gene Ther 2000; 7: 1034-1038.